BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ding HG, Shan J, Zhang B, Ma HB, Zhou L, Jin R, Tan YF, He LX. Combined human growth hormone and lactulose for prevention and treatment of multiple organ dysfunction in patients with severe chronic hepatitis B. World J Gastroenterol 2005; 11(19): 2981-2983 [PMID: 15902741 DOI: 10.3748/wjg.v11.i19.2981]
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2981.htm
Number Citing Articles
1
Jie Yang, Qing-He Nie, An-Hui Wang, Xiao-Feng Huang, Qing-Quan Liu, Yun-Ming Li. Effects of intestinal intervention on bacterial translocation in a rat model of acute liver failure in vivoEuropean Journal of Gastroenterology & Hepatology 2010; 22(11): 1316 doi: 10.1097/MEG.0b013e32833ccaae
2
N. Li, L. Zhou, B. Zhang, P. Dong, W. Lin, H. Wang, R. Xu, H. Ding. Recombinant human growth hormone increases albumin and prolongs survival in patients with chronic liver failure: A pilot open, randomized, and controlled clinical trialDigestive and Liver Disease 2008; 40(7): 554 doi: 10.1016/j.dld.2007.11.011
3
Cemalettin Ulusoy, Goncagül Haklar, Şafak Kızıltaş, Neşe İmeryüz, Ali Yaman. Serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3 levels in patients with chronic hepatitis B / Kronik hepatit B hastalarında serum insülin benzeri büyüme faktörü 1 (IGF-1) ve insülin benzeri büyüme faktörü bağlayıcı protein 3 (IGFBP-3) düzeyleriTurkish Journal of Biochemistry 2016; 41(4): 263 doi: 10.1515/tjb-2016-0038
4
Madisyn Oxley, Heather Francis, Keisaku Sato. Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and ControversiesSeminars in Liver Disease 2023; 43(01): 024 doi: 10.1055/a-2015-1359
5
Bioactive Peptides2010; : 275 doi: 10.1201/EBK1439813621-c8